Medtronic MiniMed 780G Insulin Pump Recall (Jul 13, 2026)

Source: FDA · International

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medtronic MiniMed, Inc. is recalling 257 MiniMed 780G insulin pumps (models MMT-1885CLW and MMT-1886CLW) distributed internationally.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 9, 2026 and geographically references International. The FDA classifies this as a Class II recall, with the stated reason "Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis.", distributed international distribution to the countries of germany, denmark, austria, netherlands, united kingdom, italy, belgium, ireland, switzerland, sweden, northern ireland.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

It is tempting to skim, check personal relevance, and move on. The better habit is confirming scope, source, and timestamp first, then reading this alongside related notices instead of drawing a conclusion from one record alone.

The original agency source is linked below so you can verify this record directly before acting on it. Its related labels are recall, product-safety, fda, medical-devices.

What Happened

Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis.

Which Products Are Affected

MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW. A total of 257 units are affected. The recall covers specific serial numbers listed under UDI-DI 00763000442187 and 00763000974374 for MMT-1885CLW and UDI-DI 00763000442194 and 00763000974381 for MMT-1886CLW. Distribution was international to Germany, Denmark, Austria, Netherlands, United Kingdom, Italy, Belgium, Ireland, Switzerland, Sweden, and Northern Ireland. Recall number Z-2982-2026. Classification: Class II. Status: Ongoing.

What You Should Do

No specific consumer action steps are provided in the recall notice.

Why This Matters

The potential for insulin over- or under-delivery poses risks of hypoglycemia, hyperglycemia, or diabetic ketoacidosis.

Source

FDA recall number Z-2982-2026, event ID 99374. Recalling firm: Medtronic MiniMed, Inc., Northridge, CA.

Original source: FDA Official Notice ↗

All FDA Recalls →

Elsewhere in the country: similar length or severity timing 8

Two cross-category peer sets, both computed from Areazine's own archive: notices with a similar body length, and notices near the same severity and agency date. These are drawn from other categories, not the same-feed Related list above.

Frequently Asked Questions

What people usually ask about a notice like this one.

What is this FDA recall about?
Medtronic MiniMed, Inc. is recalling 257 MiniMed 780G insulin pumps (models MMT-1885CLW and MMT-1886CLW) distributed internationally.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How is this recall classified, and why does that matter?
The FDA classifies this as a Class II recall, citing "Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis." as the reason. Class I is the most serious (reasonable probability of serious harm), Class II is a moderate or temporary health risk, and Class III is unlikely to cause harm.
What area is affected?
This alert affects International. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.